Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of levonorgestrel 1.5 mg tablets vs Postinor 1 in healthy Thai female volunteers under fasting
TCTR20220926004Phase 1Unknown
- Sponsor
- Bio-innova
- Start
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of Aftera in contraception (2 arms), sponsored by Bio-innova. Status: unknown.
02
Drugs
Aftera
03
Conditions
contraception
Beyond the preview
Go deeper on TCTR20220926004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220926004.